Tandem Diabetes Care, Inc. (TNDM) Q1 2025 Earnings Conference Call TranscriptSeeking Alpha • 05/01/25
Tandem Diabetes Care (TNDM) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 05/01/25
Tap Into the Silver Economy Boom With These Aging Demographics StocksZacks Investment Research • 04/14/25
Tandem Diabetes Care (TNDM) Moves 7.6% Higher: Will This Strength Last?Zacks Investment Research • 04/10/25
Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025Business Wire • 04/03/25
TNDM Stock Gains on the Commercial Launch of Control-IQ+ TechnologyZacks Investment Research • 03/19/25
Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 DiabetesBusiness Wire • 03/19/25
Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United StatesBusiness Wire • 03/18/25
Tandem Diabetes Crashes 32% As Light Outlook Rattles Pump-Maker's SharesInvestors Business Daily • 02/27/25
TNDM Stock Falls in Aftermarket Following Q4 Earnings and Revenue MissZacks Investment Research • 02/27/25
Here's What Key Metrics Tell Us About Tandem Diabetes Care (TNDM) Q4 EarningsZacks Investment Research • 02/27/25
Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Lags Revenue EstimatesZacks Investment Research • 02/26/25
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial GuidanceBusiness Wire • 02/26/25
Tandem Diabetes Care (TNDM) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance MeasuresZacks Investment Research • 02/25/25
Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 DiabetesBusiness Wire • 02/25/25